National Health (Price and Special Patient Contribution) Amendment Determination 2016 (No. 4) (PB 42 of 2016) (Cth)

Case

PB 42 of 2016

National Health (Price and Special Patient Contribution) Amendment Determination 2016 (No. 4)

National Health Act 1953

I, PENNY SHAKESPEARE, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this Determination under section 85B of the National Health Act 1953.

Dated                        27th May 2016

PENNY SHAKESPEARE
First Assistant Secretary
Pharmaceutical Benefits Division
Department of Health

1          Name of Instrument

(1)        This Instrument is the National Health (Price and Special Patient Contribution) Amendment Determination 2016 (No. 4).

(2)        This Instrument may also be cited as PB 42 of 2016.

2          Commencement

This Instrument commences on 1 June 2016.

3          Amendment of the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010)

Schedule 1 amends the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010).

Schedule 1     Amendments

[1] Schedule 1, entry for Alendronic acid with colecalciferol

insert as first item in the columns in the order indicated:

Tablet 70 mg (as alendronate sodium) with 70 micrograms colecalciferol Oral Fosamax Plus 4 26.91 29.23

[2]Schedule 1, after entry entry for Alendronic acid with colecalciferol in the form Tablet 70 mg (as alendronate sodium) with
140 micrograms colecalciferol

insert:

Alendronic acid with colecalciferol and calcium Pack containing 4 tablets containing alendronic acid 70 mg (as alendronate sodium) with 140 micrograms colecalciferol and 48 tablets calcium 500 mg (as carbonate) Oral Fosamax Plus
D-Cal 		4 27.50 29.83

[3] Schedule 1, entry for Amoxycillin in the form Capsule 250 mg (as trihydrate)

omit from the column headed “Claimed Price”:          3.44        substitute:             3.87

[4] Schedule 1, entry for Amoxycillin in the form Capsule 500 mg (as trihydrate)

omit from the column headed “Claimed Price”:          4.28        substitute:             4.73

[5] Schedule 1, entry for Amoxycillin in the form Powder for oral suspension 125 mg (as trihydrate) per 5 mL, 100 mL

omit from the column headed “Claimed Price”:          3.35        substitute:             3.77

[6] Schedule 1, entry for Amoxycillin in the form Powder for oral suspension 250 mg (as trihydrate) per 5 mL, 100 mL

omit from the column headed “Claimed Price”:          3.68        substitute:             4.11

[7]Schedule 1, entry for Amoxycillin with Clavulanic Acid in the form Powder for oral suspension containing 125 mg amoxycillin (as trihydrate) with 31.25 mg clavulanic acid (as potassium clavulanate) per 5 mL, 75 mL

omit from the column headed “Claimed Price”:          3.90        substitute:             4.32

[8]Schedule 1, entry for Amoxycillin with Clavulanic Acid in the form Powder for oral suspension containing 400 mg amoxycillin (as trihydrate) with 57 mg clavulanic acid (as potassium clavulanate) per 5 mL, 60 mL

omit from the column headed “Claimed Price”:          5.51        substitute:             6.09

[9]Schedule 1, entry for Amoxycillin with Clavulanic Acid in the form Tablet containing 500 mg amoxycillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate)

omit from the column headed “Claimed Price”:          5.75        substitute:             6.34

  1. Schedule 1, entry for Amoxycillin with Clavulanic Acid in the form Tablet containing 875 mg amoxycillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate)

    omit from the column headed “Claimed Price”:          7.63        substitute:             8.38

  2. Schedule 1, entry for Bisoprolol in the form Tablet containing bisoprolol fumarate 2.5 mg

    omit from the column headed “Claimed Price”:          12.77     substitute:             13.96

  3. Schedule 1, entry for Bisoprolol in the form Tablet containing bisoprolol fumarate 5 mg

    omit from the column headed “Claimed Price”:          15.43     substitute:             16.62

  4. Schedule 1, entry for Bisoprolol in the form Tablet containing bisoprolol fumarate 10 mg

    omit from the column headed “Claimed Price”:          18.76     substitute:             19.95

  5. Schedule 1, entry for Candesartan in the form Tablet containing candesartan cilexetil 4 mg

    omit from the column headed “Claimed Price”:          2.30        substitute:             2.60

  6. Schedule 1, entry for Candesartan in the form Tablet containing candesartan cilexetil 8 mg

    omit from the column headed “Claimed Price”:          3.76        substitute:             4.06

  7. Schedule 1, entry for Candesartan in the form Tablet containing candesartan cilexetil 16 mg

    omit from the column headed “Claimed Price”:          8.14        substitute:             8.44

  8. Schedule 1, entry for Candesartan in the form Tablet containing candesartan cilexetil 32 mg

    omit from the column headed “Claimed Price”:          9.51        substitute:             9.81

  9. Schedule 1, entry for Candesartan with Hydrochlorothiazide in the form Tablet containing candesartan cilexetil 16 mg with hydrochlorothiazide 12.5 mg

    omit from the column headed “Claimed Price”:          9.77        substitute:             9.95

  10. Schedule 1, entry for Candesartan with Hydrochlorothiazide in the form Tablet containing candesartan cilexetil 32 mg with hydrochlorothiazide 12.5 mg

    omit from the column headed “Claimed Price”:          11.11     substitute:             11.32

  11. Schedule 1, entry for Candesartan with Hydrochlorothiazide in the form Tablet containing candesartan cilexetil 32 mg with hydrochlorothiazide 25 mg

    omit from the column headed “Claimed Price”:          12.75     substitute:             12.83

  12. Schedule 1, entry for Carmellose in each of the forms: Eye drops containing carmellose sodium 5 mg per mL, single dose units 0.4 mL, 30; and Eye drops containing carmellose sodium 10 mg per mL, single dose units 0.4 mL, 30

    omit from the column headed “Claimed Price”:          7.59        substitute:             8.63

  13. Schedule 1, after entry entry for Doxycycline in the form Capsule 50 mg (as hydrochloride) (containing enteric coated pellets) [Brand: Mayne Pharma Doxycycline]

    insert:

Duloxetine Capsule 30 mg (as hydrochloride) Oral Cymbalta 28 6.08 8.87
Capsule 60 mg (as hydrochloride) Oral Cymbalta 28 8.67 11.46

  1. Schedule 1, entry for Escitalopram in the form Tablet 10 mg (as oxalate)

    omit from the column headed “Claimed Price”:          7.99        substitute:             9.28

  2. Schedule 1, entry for Escitalopram in the form Tablet 20 mg (as oxalate)

    omit from the column headed “Claimed Price”:          8.26        substitute:             9.62

  3. Schedule 1, after entry entry for Ipratropium in the form Nebuliser solution containing ipratropium bromide 500 micrograms (anhydrous) in 1 mL single dose units, 30

    insert:

Irbesartan Tablet 75 mg Oral Avapro 30 1.96 3.73
Karvea 30 1.96 3.73
Tablet 150 mg Oral Avapro 30 2.80 4.57
Karvea 30 2.80 4.57
Tablet 300 mg Oral Avapro 30 5.58 7.35
Karvea 30 5.58 7.35
Irbesartan with hydrochlorothiazide Tablet 150 mg-12.5 mg Oral Avapro HCT 150/12.5 30 3.98 5.75
Karvezide 150/12.5 30 3.98 5.75
Tablet 300 mg-12.5 mg Oral Avapro HCT 300/12.5 30 7.09 8.85
Karvezide 300/12.5 30 7.09 8.85
Tablet 300 mg-25 mg Oral Avapro HCT 300/25 30 7.96 9.73
Karvezide 300/25 30 7.96 9.73

  1. Schedule 1, entry for Labetalol in the form Tablet containing labetalol hydrochloride 100 mg

    omit from the column headed “Claimed Price”:          10.15     substitute:             11.05

  2. Schedule 1, entry for Labetalol in the form Tablet containing labetalol hydrochloride 200 mg

    omit from the column headed “Claimed Price”:          14.85     substitute:             15.58

  3. Schedule 1, entry for Lisinopril in the form Tablet 5 mg [Brand: Zestril]

    omit from the column headed “Claimed Price”:          5.07        substitute:             5.41

  4. Schedule 1, entry for Lisinopril in the form Tablet 5 mg [Brand: Zestril]

    omit from the column headed “Claimed Price”:          6.22        substitute:             6.57

  5. Schedule 1, entry for Lisinopril in the form Tablet 5 mg [Brand: Zestril]

    omit from the column headed “Claimed Price”:          7.16        substitute:             7.48

  6. Schedule 1, entry for Meloxicam in the form Capsule 7.5 mg

    omit from the column headed “Claimed Price”:          5.29        substitute:             5.55

  7. Schedule 1, entry for Meloxicam in the form Capsule 15 mg

    omit from the column headed “Claimed Price”:          6.76        substitute:             7.03

  8. Schedule 1, entry for Meloxicam in the form Tablet 7.5 mg

    omit from the column headed “Claimed Price”:          5.29        substitute:             5.55

  9. Schedule 1, entry for Meloxicam in the form Tablet 15 mg

    omit from the column headed “Claimed Price”:          6.76        substitute:             7.03

  10. Schedule 1, entry for Mirtazapine in the form Tablet 15 mg (orally disintegrating)

    omit from the column headed “Claimed Price”:          5.43        substitute:             5.64

  11. Schedule 1, entry for Mirtazapine in the form Tablet 30 mg

    omit from the column headed “Claimed Price”:          6.61        substitute:             7.19

  12. Schedule 1, entry for Mirtazapine in the form Tablet 30 mg (orally disintegrating)

    omit from the column headed “Claimed Price”:          6.94        substitute:             7.13

  13. Schedule 1, entry for Mirtazapine in the form Tablet 45 mg

    omit from the column headed “Claimed Price”:          9.23        substitute:             9.80

  1. Schedule 1, entry for Mirtazapine in the form Tablet 45 mg (orally disintegrating)

    omit from the column headed “Claimed Price”:          9.99        substitute:             10.18

  2. Schedule 1, entry for Mometasone in the form Cream containing mometasone furoate 1 mg per g, 15 g

    omit from the column headed “Claimed Price”:          5.96        substitute:             6.36

  3. Schedule 1, entry for Mometasone in the form Lotion containing mometasone furoate 1 mg per g, 30 mL

    omit from the column headed “Claimed Price”:          8.18        substitute:             8.58

  4. Schedule 1, entry for Mometasone in the form Ointment containing mometasone furoate 1 mg per g, 15 g

    omit from the column headed “Claimed Price”:          5.96        substitute:             6.36

  5. Schedule 1, after entry entry for Mometasone in the form Ointment containing mometasone furoate 1 mg per g, 15 g

    insert:

Montelukast Tablet, chewable, 4 mg (as sodium) Oral Singulair 28 12.39 14.25

  1. Schedule 1, entry for Omeprazole

    omit from the column headed “Claimed Price”:          7.20        substitute:             7.59

  2. Schedule 1, entry for Perindopril [Brands: Coversyl 2.5mg; PREXUM 2.5]

    omit from the column headed “Claimed Price”:          3.65        substitute:             3.86

  3. Schedule 1, entry for Perindopril with amlodipine in the form Tablet containing 5 mg perindopril arginine with 5 mg amlodipine (as besylate)

    (a)   omit from the column headed “Determined Price”:             16.73     substitute:             4.82

    (b)   omit from the column headed “Claimed Price”:                  18.55     substitute:             6.63

  4. Schedule 1, entry for Perindopril with amlodipine in the form Tablet containing 5 mg perindopril arginine with 10 mg amlodipine (as besylate)

    (a)   omit from the column headed “Determined Price”:             22.67     substitute:             5.58

    (b)   omit from the column headed “Claimed Price”:                  27.27     substitute:             10.18

  5. Schedule 1, entry for Perindopril with amlodipine in the form Tablet containing 10 mg perindopril arginine with 5 mg amlodipine (as besylate)

    (a)   omit from the column headed “Determined Price”:             21.45     substitute:             6.85

    (b)   omit from the column headed “Claimed Price”:                  23.26     substitute:             8.67

  1. Schedule 1, entry for Perindopril with amlodipine in the form Tablet containing 10 mg perindopril arginine with 10 mg amlodipine (as besylate)

    (a)   omit from the column headed “Determined Price”:             27.37     substitute:             7.61

    (b)   omit from the column headed “Claimed Price”:                  29.18     substitute:             9.41

  2. Schedule 1, entry for Ranitidine in each of the forms: Tablet 150 mg (as hydrochloride); and Tablet 300 mg (as hydrochloride)

    omit from the column headed “Claimed Price”:          4.86        substitute:             6.14

  3. Schedule 1, after entry for Ranitidine in the form Tablet 300 mg (as hydrochloride)

    insert in the columns in the order indicated:

Tablet, effervescent, 150 mg (as hydrochloride) Oral Zantac 30 2.17 2.82

  1. Schedule 1, entry for Salbutamol in the form Pressurised inhalation 100 micrograms (as sulfate) per dose, 200 doses (CFC-free formulation)

    omit:

Asmol CFC-free 1 2.99 3.45

  1. Schedule 1, entry for Simvastatin in the form Tablet 10 mg [Brands: Lipex 10; Zocor]

    omit from the column headed “Claimed Price”:          5.10        substitute:             6.03

  2. Schedule 1, entry for Simvastatin in the form Tablet 20 mg [Brands: Lipex 20; Zocor]

    omit from the column headed “Claimed Price”:          5.72        substitute:             6.65

  3. Schedule 1, entry for Simvastatin in the form Tablet 40 mg [Brands: Lipex 40; Zocor]

    omit from the column headed “Claimed Price”:          6.59        substitute:             7.52

  4. Schedule 1, entry for Simvastatin in the form Tablet 80 mg [Brands: Lipex 80; Zocor]

    omit from the column headed “Claimed Price”:          7.84        substitute:             8.77

  5. Schedule 1, entry for Telmisartan in the form Tablet 40 mg

    omit from the column headed “Claimed Price”:          4.68        substitute:             4.84

  6. Schedule 1, entry for Telmisartan in the form Tablet 80 mg

    omit from the column headed “Claimed Price”:          11.01     substitute:             11.17

  7. Schedule 1, entry for Telmisartan with amlodipine in the form Tablet 40 mg-5 mg (as besylate)

    omit from the column headed “Claimed Price”:          5.21        substitute:             5.77

  8. Schedule 1, entry for Telmisartan with amlodipine in the form Tablet 40 mg-10 mg (as besylate)

    omit from the column headed “Claimed Price”:          5.91        substitute:             6.48

  9. Schedule 1, entry for Telmisartan with amlodipine in the form Tablet 80 mg-5 mg (as besylate)

    omit from the column headed “Claimed Price”:          11.54     substitute:             12.10

  10. Schedule 1, entry for Telmisartan with amlodipine in the form Tablet 80 mg-10 mg (as besylate)

    omit from the column headed “Claimed Price”:          12.25     substitute:             12.81

  11. Schedule 1, entry for Telmisartan with hydrochlorothiazide in the form Tablet 40 mg-12.5 mg

    omit from the column headed “Claimed Price”:          5.72        substitute:             5.95

  12. Schedule 1, entry for Telmisartan with hydrochlorothiazide in the form Tablet 80 mg-12.5 mg

    omit from the column headed “Claimed Price”:          12.35     substitute:             12.58

  13. Schedule 1, entry for Telmisartan with hydrochlorothiazide in the form Tablet 80 mg-25 mg

    omit from the column headed “Claimed Price”:          13.34     substitute:             13.57

  14. Schedule 1, entry for Zolmitriptan

    omit from the column headed “Claimed Price”:          8.19        substitute:             8.32

Actions
Download as PDF Download as Word Document
Cases Citing This Decision

0

Cases Cited

0

Statutory Material Cited

0